brl 42810 has been researched along with AIDS Seroconversion in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy and safety of 7 days' treatment with famciclovir 500 mg twice a day versus acyclovir 400 mg five times a day, for mucocutaneous herpes simplex virus (HSV) infection in HIV-infected individuals." | 5.09 | Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group. ( Aoki, FY; Lavender, EA; Martel, AY; Parsons, JE; Romanowski, B; Saltzman, RL, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keating, TM | 1 |
| Kurth, AE | 1 |
| Wald, A | 1 |
| Kahle, EM | 1 |
| Barash, EA | 1 |
| Buskin, SE | 1 |
| Romanowski, B | 1 |
| Aoki, FY | 1 |
| Martel, AY | 1 |
| Lavender, EA | 1 |
| Parsons, JE | 1 |
| Saltzman, RL | 1 |
1 trial available for brl 42810 and AIDS Seroconversion
| Article | Year |
|---|---|
Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.
Topics: 2-Aminopurine; Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Double-Bli | 2000 |
1 other study available for brl 42810 and AIDS Seroconversion
| Article | Year |
|---|---|
Clinical burden of herpes simplex virus disease in people with human immunodeficiency virus.
Topics: 2-Aminopurine; Acyclovir; Adult; Antiviral Agents; Comorbidity; Famciclovir; Female; Herpes Simplex; | 2012 |